Combined oxidative phosphorylation deficiency caused by mutation in VARS2 is a very rare genetic disease. Doctors also call it Combined oxidative phosphorylation deficiency 20 (COXPD20). In this disease, both copies of the VARS2 gene have harmful changes. Because of this, the mitochondria (the “power stations” of the cell) cannot make enough energy using oxidative phosphorylation, which is the main way our cells turn food into usable energy. [1]
Combined oxidative phosphorylation deficiency caused by mutation in VARS2 is a very rare genetic mitochondrial disease. In this condition, both copies of the VARS2 gene (on chromosome 6) are changed, so the body makes a faulty enzyme called mitochondrial valyl-tRNA synthetase. This enzyme is needed to build proteins inside mitochondria, the “power plants” of the cell. When it does not work, several parts of the respiratory chain (especially complexes I and IV) fail, and cells cannot make enough energy (ATP). This can cause a mix of brain, heart, muscle, and metabolic problems such as developmental delay, weak or stiff muscles, seizures, lactic acidosis, and cardiomyopathy, usually starting in infancy or early childhood.
The VARS2 gene gives the body instructions to make an enzyme called mitochondrial valyl-tRNA synthetase. This enzyme is needed to build mitochondrial proteins that form parts of the respiratory chain complexes (mainly complexes I, III, IV and V). When VARS2 does not work well, many of these complexes work poorly, so the energy level in cells becomes very low, especially in the brain, heart and muscles, which need a lot of energy. [2]
Because energy production is low, many organs can be affected. Babies or children may have weak muscles, poor head control, slow development, seizures (fits), feeding problems, small head size, heart muscle disease (cardiomyopathy), and sometimes breathing problems. Blood tests often show high lactic acid (lactic acidosis), which is a sign that cells are trying to make energy in a less efficient backup way. [1][3]
This condition is usually autosomal recessive. That means a child becomes ill only when they receive one non-working VARS2 gene from each parent. The parents are usually healthy “carriers”. The illness is very rare worldwide, and only a small number of families have been described in medical studies. [2][3][4]
Doctors sometimes call this condition “combined oxidative phosphorylation deficiency 20 (COXPD20)” or “VARS2-related mitochondrial encephalocardiomyopathy.” It is inherited in an autosomal recessive way, which means both parents usually carry one silent copy of the gene. The course can be severe, but the exact symptoms and speed of progression are different from child to child. At present, there is no cure. Treatment focuses on careful supportive care, avoiding extra stress on the mitochondria, and treating each organ problem early using a team of specialists.
Other names
Doctors and researchers may use different names for the same disease. Knowing them helps you find information:
-
Combined oxidative phosphorylation deficiency 20 (COXPD20) – the most common full name. [1][3]
-
Combined oxidative phosphorylation defect type 20 – another way to say the same thing. [1]
-
VARS2-related mitochondrial disease – this focuses on the gene that is changed. [4][5]
-
VARS2-related mitochondrial encephalomyopathy or cardiomyopathy – used when brain and muscle, or mainly heart, are most affected. [4][5]
All these names point to one group of diseases caused by harmful variants in the VARS2 gene.
Types (clinical patterns)
Because the same gene can give different problems in different people, doctors often describe types based on age of onset and main organs involved: [3][4][5]
-
Neonatal lethal cardiomyopathic type
In this type, problems start in the first days or weeks of life. Babies may have severe heart muscle thickening (hypertrophic cardiomyopathy), strong lactic acidosis, weak feeding, and breathing difficulty. Sadly, many of these babies die early, often from heart failure or severe high blood pressure in the lungs. [5] -
Early-infantile encephalomyopathy type
Here, symptoms start in the first months of life. Babies have low muscle tone (floppy baby), poor head control, feeding difficulties, developmental delay, and seizures. Brain scans show damage or abnormal development. The heart may or may not be involved. [4][5] -
Childhood-onset epileptic encephalopathy / progressive myoclonic epilepsy type
In some children, early development may be almost normal or only mildly delayed. Later they develop epilepsy (often hard to control), jerking muscle movements (myoclonus), and loss of skills they had before. This pattern has been described as progressive myoclonic epilepsy linked to VARS2. [4][5] -
Milder, longer-surviving multisystem type
A few patients live into later childhood or adolescence. They may have learning problems, movement difficulties (ataxia, spasticity), seizures that can sometimes be controlled, and mild heart or liver problems. They still have a serious disease, but the course is slower than in the neonatal form. [4][5]
Causes
Remember: the root cause is always damaging changes in both copies of the VARS2 gene. The items below describe different ways or conditions that lead to the same final problem of low mitochondrial energy. [2][3][4][5]
-
Biallelic pathogenic VARS2 variants
The main cause is having two harmful changes (variants) in VARS2, one from each parent. These variants change the protein so much that it cannot do its job properly, and mitochondrial protein building fails. [3][4] -
Missense variants in important regions of VARS2
Some patients have “missense” variants, where one amino acid in the protein is swapped for another in a critical part of the enzyme. This can change the shape of the enzyme so it cannot attach valine to tRNA correctly. [4] -
Nonsense or frameshift variants in VARS2
Other patients have variants that create a stop signal too early (nonsense) or shift the reading frame (frameshift). The body then makes a very short, non-functional enzyme or destroys the faulty message, leaving almost no enzyme. [4][5] -
Splice-site variants in VARS2
Some variants occur at the borders between exons and introns and disturb RNA splicing. Abnormal splicing produces a mis-shaped protein that cannot work, again lowering mitochondrial protein production. [4] -
Complete or near-complete loss of VARS2 function
When both copies of the gene give little or no working enzyme, the mitochondria cannot make enough of multiple respiratory chain complexes. This leads to a “combined” oxidative phosphorylation deficiency, not just a defect in one complex. [3] -
Partial loss of function (hypomorphic variants)
Some variants leave a small amount of enzyme activity. These may cause a milder or slower form of the disease, because mitochondria can still make some, but not enough, energy. [4][5] -
Consanguinity (parents related by blood)
When parents are related (for example, cousins), they are more likely to carry the same rare VARS2 variant. This increases the chance that their child will inherit the same harmful variant from both sides. [2][4] -
Mitochondrial respiratory chain complex I deficiency
Many patients with VARS2 changes have particularly low activity of complex I in muscle or fibroblast tests. Complex I is the first large protein machine in the respiratory chain, and its failure greatly reduces ATP production. [1][3] -
Combined deficiency of several complexes
Because VARS2 acts at a very early step of mitochondrial protein production, several complexes (I, III, IV, V) can be affected at once. This “combined” deficit explains the severe and widespread symptoms in brain, heart and muscle. [3][4] -
High energy demand in heart muscle
Heart muscle cells need a lot of energy to pump blood all the time. When mitochondria in these cells do not work well, the heart muscle becomes thickened and stiff (hypertrophic cardiomyopathy). This is a main cause of heart problems in this disease. [5] -
High energy demand in brain cells
Brain cells also require constant energy. If mitochondrial energy is low, brain development and function suffer, leading to seizures, developmental delay, and movement problems. [1][4][5] -
High energy demand in skeletal muscle
Muscle cells use large amounts of energy, especially during movement. Weakness and low muscle tone arise because their mitochondria cannot provide enough ATP for normal contraction. [1][3] -
Accumulation of lactic acid
When cells cannot get enough energy from oxidative phosphorylation, they switch more to anaerobic glycolysis, which produces lactic acid. This buildup of lactate in blood and tissues contributes to acidosis and can worsen symptoms, especially in stress or illness. [1][3] -
Acute infections as triggers
Fevers and infections increase the body’s energy needs. In a child with VARS2-related disease, infection can trigger or worsen lactic acidosis, seizures, or heart failure, leading to sudden clinical deterioration. [4][5] -
Fasting or poor feeding
When a baby or child does not eat well, the body has less fuel to make energy. In mitochondrial disease, this stress can worsen acidosis and weakness. Frequent feeding and avoiding long fasts are important in care. [4][5] -
Certain anesthetic or sedative drugs
Some drugs can put extra stress on mitochondria or heart function. In children with mitochondrial cardiomyopathy, anesthesia must be carefully planned to avoid worsening heart or respiratory problems. [4] -
Other illnesses that reduce oxygen delivery
Conditions such as severe anemia or lung disease reduce oxygen supply to tissues. For a person who already has poor oxidative phosphorylation, lower oxygen can further reduce energy production and worsen symptoms. -
Metabolic stress during rapid growth
Infancy and early childhood are times of very fast growth. The body needs a lot of energy to build tissues. In VARS2 disease, the mitochondria cannot meet this high demand, making symptoms more obvious during this period. [4] -
Modifier genes
Other genes involved in mitochondrial function may make the disease more or less severe. This may explain why patients with similar VARS2 variants can have different levels of symptoms. [4] -
Environmental and nutritional factors
Lack of certain vitamins or cofactors needed for mitochondrial enzymes, or exposure to toxins that harm mitochondria, can add to the effect of VARS2 variants and make the disease more severe, though the primary cause is still genetic.
Symptoms
Not every patient has every symptom, but these are commonly reported: [1][2][3][4][5]
-
Developmental delay
Babies may learn to smile, sit, stand or walk later than usual. They may need extra help and therapy to achieve milestones. Some children stop gaining new skills or lose skills they had before. -
Low muscle tone (hypotonia)
Many infants feel “floppy” when held. Their muscles do not resist movement much. This makes it hard to hold up the head, sit without support, or feed. -
Muscle weakness
As children grow, they may have trouble lifting the head, crawling, standing, or walking. Older children can tire easily when climbing stairs or running. Weakness often affects the trunk and limbs. -
Seizures (epilepsy)
Many patients have seizures, which can be focal, generalized, or myoclonic (quick jerks). Seizures can be frequent and may not respond well to standard anti-seizure medicines. -
Progressive myoclonic jerks
In some children, there are frequent shock-like jerks of the arms or whole body. These jerks may get worse over time and can make daily activities difficult. -
Feeding difficulties and poor sucking
Newborns and infants may have weak sucking and swallowing. They take a long time to feed and may not gain weight well. Some need feeding tubes to get enough nutrition. [5] -
Failure to thrive and poor growth
Because of low energy and feeding problems, children may not gain weight and height as expected. Doctors call this “failure to thrive”. -
Lactic acidosis symptoms
High lactic acid in the blood can cause fast breathing, vomiting, tiredness, and sometimes changes in consciousness. During infections or stress, lactic acidosis can become life-threatening. [1][3] -
Hypertrophic cardiomyopathy
Many babies with VARS2 variants develop thickened heart muscle. This can lead to poor pumping, heart rhythm problems, and heart failure. Symptoms include poor feeding, sweating, and fast breathing. [5] -
Pulmonary hypertension and respiratory distress
Some infants develop high blood pressure in the lung arteries (pulmonary hypertension). They may breathe fast, turn blue around the lips, and need oxygen or ventilation. [5] -
Microcephaly (small head size)
In some children, the head size is smaller than normal for age. This often reflects underlying problems in brain growth or loss of brain tissue. [1][2] -
Abnormal brain imaging findings
MRI scans may show abnormal white matter, brain atrophy (shrinkage), or changes in deep brain structures. These changes can relate to movement problems and seizures. [4][5] -
Movement disorders (ataxia or spasticity)
Some children have shaky or unsteady movements (ataxia) or stiff, tight muscles (spasticity). These movement problems can affect walking, hand use, and speech. [4] -
Ptosis and eye movement problems
A few patients have droopy eyelids (ptosis) or trouble moving the eyes normally (external ophthalmoplegia). These signs come from weak eye muscles or nerve involvement. [3] -
Mild facial differences and other organ signs
Some children have mild facial features such as a high forehead or low-set ears, and some have abnormal liver tests or other organ involvement. These findings are usually not specific but support a multisystem disease picture. [2][3]
Diagnostic tests
Doctors use a mix of clinical examination and special tests to diagnose VARS2-related combined oxidative phosphorylation deficiency. Often, diagnosis is confirmed only after genetic testing. [1][2][3][4][5]
Physical exam tests
-
General physical and growth examination
The doctor measures weight, length/height, and head circumference and compares them with age charts. They also look for signs of poor growth, small head size, and facial differences. This gives an overall picture of the child’s health and development. -
Neurological examination
The doctor checks muscle tone, strength, reflexes, coordination, and responses to touch and sound. They look for hypotonia, weakness, abnormal movements, and developmental delay, which are common in mitochondrial disease. -
Cardiac and respiratory examination
Listening with a stethoscope can reveal extra heart sounds, murmurs, or signs of heart failure. The doctor also checks breathing rate, effort, and oxygen levels, looking for heart or lung complications.
Manual (bedside functional) tests
-
Muscle strength testing
In older children, the doctor asks them to push or pull against resistance, stand up from sitting, or climb stairs. These simple tasks help grade muscle strength and see how weakness affects daily life. -
Tone and reflex assessment
The doctor gently moves the child’s arms and legs to feel how stiff or floppy they are and taps tendons to check reflexes. Abnormal tone and reflexes support a neurological or neuromuscular problem. -
Developmental and functional scales
Standard tools (for example, Bayley or similar developmental scales) may be used to rate motor, language, and social skills. This helps measure how delayed the child is and follow progress over time.
Laboratory and pathological tests
-
Serum lactate and pyruvate levels
Blood tests for lactate and pyruvate are key. Persistently high lactate, especially with high lactate-to-pyruvate ratio, suggests mitochondrial energy failure. Doctors may repeat tests or check levels during illness or after feeding. [1][3] -
Blood gas analysis
Arterial or capillary blood gases show pH and bicarbonate levels. Metabolic acidosis (low pH, low bicarbonate) with high lactate supports mitochondrial disease and guides urgent treatment during crises. -
Creatine kinase (CK) and other muscle enzymes
CK, AST, ALT and LDH may be mildly or moderately elevated, showing muscle or liver stress. While not specific, these enzymes help show that muscle and other tissues are affected. -
Comprehensive metabolic panel
Tests for liver function, kidney function, glucose, and electrolytes show how different organs are working and help rule out other causes of symptoms such as liver failure or kidney disease. -
Plasma amino acids and acylcarnitine profile
These tests look for patterns typical of other metabolic diseases. In many mitochondrial disorders, results are non-specific or mildly abnormal, but they help rule out conditions that can mimic VARS2 disease. -
Urine organic acids
Analysis of organic acids in urine may show high lactic acid and other metabolites related to impaired energy metabolism. This again suggests a mitochondrial process and supports further testing. -
Muscle biopsy with histology and respiratory chain studies
A small sample of muscle can be taken and examined under the microscope and by special enzyme tests. Findings may include abnormal mitochondria and reduced activity of several respiratory chain complexes, especially complex I. [3][4]
Electrodiagnostic tests
-
Electroencephalogram (EEG)
EEG records electrical activity in the brain. It can show epileptic discharges in children with seizures and sometimes a background pattern suggesting metabolic encephalopathy. This helps classify and manage epilepsy. [4] -
Electromyography and nerve conduction studies (EMG/NCS)
These tests measure how muscles and nerves respond to small electrical impulses. They can show whether weakness is due mainly to muscle disease, nerve disease, or central nervous system problems. -
Electrocardiogram (ECG) and Holter monitoring
ECG records the electrical activity of the heart and can reveal rhythm problems. Holter monitoring records ECG over 24 hours or more, helping detect intermittent arrhythmias in children with cardiomyopathy.
Imaging tests
-
Brain MRI
MRI of the brain can show structural abnormalities, white matter changes, brainstem or basal ganglia lesions, or brain atrophy. These patterns help confirm a mitochondrial encephalopathy and may guide prognosis. [4][5] -
Cranial ultrasound in newborns
In very young babies, ultrasound through the fontanelle (soft spot) can give an early look at brain structure. It is less detailed than MRI but quick and bedside, useful in sick infants. -
Echocardiography (heart ultrasound)
Echocardiography uses sound waves to visualize the heart. It can show thickened heart muscle (hypertrophic cardiomyopathy), poor pumping, and signs of pulmonary hypertension in infants with VARS2 variants. [5] -
Further MRI (for example, spine or muscle MRI)
Additional MRI studies may be used to evaluate muscle, spine, or other structures in selected cases. They can show muscle involvement or other abnormalities that support the diagnosis and help rule out other conditions.
Non-pharmacological treatments
Non-drug treatments are the backbone of care in VARS2-related mitochondrial disease. They try to protect energy, support organs, and keep quality of life as good as possible. Most children are followed in a specialist mitochondrial or metabolic clinic with a multi-disciplinary team.
1. Regular care in a mitochondrial clinic
A specialist clinic brings together neurologists, cardiologists, metabolic doctors, dietitians, and therapists. The purpose is to spot organ problems early and adjust treatment quickly. The team checks the heart, brain, growth, nutrition, and lab tests at set times. This approach helps prevent sudden crises, such as heart failure or severe lactic acidosis, by monitoring trends instead of waiting for emergencies.
2. Physical therapy
Physical therapists design gentle, regular exercises to maintain strength, balance, and joint movement. The purpose is to reduce contractures, prevent deconditioning, and keep mobility for as long as possible. Light, supervised exercise can even improve mitochondrial efficiency and muscle endurance when done carefully, avoiding over-fatigue.
3. Occupational therapy
Occupational therapists help the child manage daily tasks such as dressing, writing, and playing. The purpose is to keep independence. They may suggest adapted tools, energy-saving techniques, or changes at home and school to match the child’s abilities and reduce strain on weak muscles.
4. Speech and feeding therapy
Speech-language therapists support swallowing and communication. In children with weak mouth or throat muscles or developmental delay, they teach safer swallowing techniques and use thickened fluids if needed. They may also introduce communication aids. This reduces the risk of choking, aspiration pneumonia, and poor nutrition.
5. Nutritional counseling
A dietitian creates an energy-rich, balanced diet tailored to the child’s growth and lab tests. The aim is to avoid malnutrition, low blood sugar, and dehydration, all of which increase mitochondrial stress. Plans may include frequent small meals, night-time feeds, or special formula in some children.
6. Avoiding fasting and dehydration
For mitochondrial disease, long gaps without food can trigger catabolic stress, lactic acidosis, and regressions. Parents are often told to avoid prolonged fasting, offer fluids during illness, and seek early medical care if the child cannot drink or eat normally. Hospitals may give glucose-containing IV fluids during sickness or before surgery to prevent metabolic crashes.
7. Infection prevention and early treatment
Because infections put big stress on energy metabolism, strict handwashing, up-to-date vaccines, and early treatment of fevers or chest infections are important. Some families have an “emergency letter” telling ER doctors how to manage fluids, glucose, and labs when the child is ill. This can reduce serious complications from infections.
8. Temperature and environment control
Children with mitochondrial disease may not tolerate very high or low temperatures. Families are taught to keep the child comfortably warm, treat fevers quickly, and avoid overheating. During surgery or anesthesia, the team carefully monitors temperature, oxygen, and blood sugars to prevent extra stress on the mitochondria.
9. Individualized exercise program
Supervised, low-to-moderate-intensity aerobic exercise, such as walking, cycling, or swimming, can improve mitochondrial biogenesis and endurance if started gently and increased slowly. The purpose is to build capacity without causing over-exertion. Patients are usually told to avoid sudden, very intense workouts and to rest when they feel exhausted.
10. Assistive mobility devices
Devices such as ankle–foot orthoses, walkers, or wheelchairs can reduce energy cost and prevent falls. The goal is not to “give up walking,” but to allow the child to move safely, conserve energy for important activities, and avoid injuries that might send them to hospital.
11. Respiratory support and airway clearance
If muscle weakness affects breathing, physiotherapists may teach breathing exercises, use devices to help cough, or recommend non-invasive ventilation at night. This can improve sleep, protect the lungs, and lower the risk of respiratory infections or failure.
12. Cardiac monitoring and lifestyle adjustments
Because hypertrophic cardiomyopathy and rhythm problems are common in VARS2 disease, regular echocardiograms and ECGs are crucial. Patients with heart involvement may need limits on intense sports, careful monitoring during dehydration, and quick attention for chest pain or palpitations.
13. Educational and developmental support
Early intervention programs, special education services, and tailored learning plans help children with developmental delay reach their potential. Teachers can adjust workload, rest breaks, and physical education to respect fatigue and motor problems.
14. Psychological support for child and family
Living with a severe rare disease is emotionally hard. Psychologists or counselors can support coping, anxiety, grief, and sibling issues. Helping parents handle stress can indirectly improve the child’s care and adherence to treatments.
15. Social work and respite care
Social workers help families access financial support, community resources, and respite care. This is important for long-term illnesses where caregivers may be exhausted. Practical help with transport, equipment, and home adaptations can make daily life more manageable.
16. Peri-operative planning with anesthesia team
If surgery is needed, pre-planning with anesthesiologists experienced in mitochondrial disease reduces risk. They try to shorten fasting, avoid lactate-containing fluids, control temperature, and choose anesthetic drugs carefully to reduce mitochondrial toxicity.
17. Emergency action plan
Families are often given a written plan for emergencies (seizure, severe vomiting, sudden weakness, or breathing problems). It usually tells local doctors what labs to check (blood gases, lactate, glucose), what fluids to use, and which drugs to avoid. Clear plans reduce delays and mistakes in crisis situations.
18. Genetic counseling
Genetic counselors explain the autosomal recessive inheritance, recurrence risk in future pregnancies, and options such as prenatal or preimplantation genetic testing. This helps parents make informed reproductive choices and also helps at-risk relatives understand carrier testing.
19. Palliative care involvement
In severe cases, palliative care teams support symptom control (for example, pain, shortness of breath), decision-making, and quality of life. Palliative care is not only for the very end of life; it can be used early alongside active treatment to reduce suffering for child and family.
20. Community and patient-group support
Joining mitochondrial disease support groups gives families information and emotional support from others with similar experiences. They also help families learn about research studies and new guidelines, so they can discuss the latest options with their doctors.
Drug treatments
There is no single medicine approved specifically to cure VARS2-related combined oxidative phosphorylation deficiency. Most drugs are used to manage symptoms such as seizures, heart failure, pulmonary hypertension, acidosis, or nutritional problems, following general mitochondrial disease guidelines. Many uses are off-label and must be supervised by specialists.
Below are examples of medicines doctors may consider. Typical dose ranges are based on FDA prescribing information for their approved indications, not for VARS2 disease itself. Exact dose, schedule, and choice of drug must always be individualized.
1. Levocarnitine (Carnitor)
Levocarnitine replaces carnitine, a molecule that carries fatty acids into mitochondria and removes toxic acyl-compounds. In mitochondrial disease, it is used to support energy production and to clear organic acids. FDA labeling for primary carnitine deficiency suggests adult oral doses around 990 mg two or three times daily, adjusted by doctors according to weight and labs. Side effects may include nausea, diarrhea, and a fishy body odor.
2. Riboflavin (vitamin B2, high-dose therapy)
Riboflavin is a cofactor for many mitochondrial dehydrogenases and electron-transfer reactions (FMN, FAD). High-dose riboflavin is sometimes added to a “mitochondrial cocktail” to support residual respiratory chain function. FDA documents describe riboflavin as generally recognized as safe and used intravenously in vitamin mixtures. Doctors usually give oral doses far above the normal dietary intake in mitochondrial patients, watching for yellow urine and rare stomach upset.
3. Thiamine (vitamin B1)
Thiamine is needed for pyruvate dehydrogenase and other enzymes that feed into the respiratory chain. High-dose thiamine may help shift pyruvate into the Krebs cycle and reduce lactate in some mitochondrial disorders. It is included in many IV multivitamin products approved by FDA. Doctors choose oral or IV doses depending on severity and coexisting deficiencies. Main side effects are rare, such as allergy with IV use.
4. Coenzyme Q10 (ubiquinone) – as a “drug-like” supplement
Coenzyme Q10 shuttles electrons between complexes I and II to complex III. In mitochondrial disease, high-dose CoQ10 is often used to support ATP production and as an antioxidant. Clinical trials show mixed but sometimes positive effects on exercise tolerance. Although CoQ10 is usually sold as a supplement (not a prescription drug), some FDA documents discuss its role in mitochondrial respiratory chain function. Side effects are usually mild, like stomach upset.
5. Alpha-lipoic acid
Alpha-lipoic acid is a cofactor for mitochondrial dehydrogenase complexes and has antioxidant properties. Some clinicians use it to reduce oxidative stress and improve glucose metabolism in mitochondrial disease. It is more often treated as a supplement, but dosing is still guided by safety data from its use in diabetic neuropathy. Side effects can include nausea or skin rash, and it must be used cautiously in children.
6. L-arginine
L-arginine may improve nitric oxide production and blood flow in certain mitochondrial stroke-like syndromes. Evidence is strongest in MELAS, but some centers consider it in other mitochondrial conditions with lactic acidosis or vascular issues. It is usually given orally or intravenously during acute episodes, with dosing based on weight and monitored for low blood pressure or electrolyte changes.
7. Levetiracetam
Levetiracetam is a common anti-seizure medicine that has relatively low mitochondrial toxicity compared with some older drugs. In children with VARS2-related seizures, neurologists may choose levetiracetam to control epilepsy while trying to protect energy production. Typical dosing is weight-based and divided twice daily. Side effects can include irritability, drowsiness, or behavior changes.
8. Lamotrigine
Lamotrigine is another seizure medication with less known mitochondrial toxicity. It is often added gradually to avoid skin reactions such as severe rash. In mitochondrial disease, it may be selected for focal seizures or generalized epilepsy when valproate is avoided. Doctors start with very low doses and slowly increase while monitoring mood and skin.
9. Sodium bicarbonate (for severe acidosis)
In acute metabolic crises with dangerous acidosis, IV sodium bicarbonate may be used in the intensive care unit. It helps buffer excess acid and raise blood pH, buying time while the underlying cause (such as infection or prolonged fasting) is treated. Too rapid correction can cause fluid shifts and electrolyte problems, so dosing is closely controlled and calculated by specialists.
10. Standard heart-failure medicines (ACE inhibitors such as enalapril)
If hypertrophic or dilated cardiomyopathy develops, cardiologists may prescribe standard heart-failure drugs like ACE inhibitors (for example, enalapril) to reduce heart workload and improve pumping. Doses follow pediatric or adult heart-failure guidelines and are adjusted for blood pressure and kidney function. Possible side effects include cough, low blood pressure, and kidney changes.
11. Beta-blockers (such as carvedilol)
Carvedilol and similar drugs slow the heart and reduce arrhythmias and stress on the heart muscle. They are often combined with ACE inhibitors in cardiomyopathy. Doctors start with very low doses and increase slowly while monitoring blood pressure, heart rate, and symptoms such as dizziness or fatigue.
12. Diuretics (such as furosemide and spironolactone)
In children with heart failure, diuretics help remove extra fluid, reduce swelling, and improve breathing. Furosemide and spironolactone are common choices. They are dosed by weight and require monitoring of electrolytes and kidney function. Over-diuresis can worsen dehydration and mitochondrial stress, so doctors balance fluid removal and energy needs.
13. Sildenafil for pulmonary hypertension (Revatio)
Some VARS2 patients have severe pulmonary hypertension. In such cases, specialists may use sildenafil (Revatio) to relax blood vessels in the lungs and reduce pressure. FDA labeling for pulmonary arterial hypertension suggests doses such as 20 mg three times daily in adults, with weight-based dosing in children, but actual dosing is individualized. Side effects include headache, flushing, and low blood pressure.
14. Proton-pump inhibitors or H2 blockers
If reflux or stomach problems occur, drugs like omeprazole or ranitidine (where still used) may protect the stomach and esophagus, making feeding easier. They reduce acid production, improving comfort and sometimes weight gain. Long-term use must be balanced against risks such as nutrient malabsorption.
15. Anti-spasticity medicines (such as baclofen)
When increased muscle tone and spasticity cause pain, contractures, or difficulty with care, baclofen or other muscle relaxants may be used. They work by reducing excitatory signals in the spinal cord. Doses are carefully titrated to avoid too much weakness or sleepiness.
16. Pain-control medicines (paracetamol, limited NSAIDs)
Simple pain relievers such as paracetamol are used for headache, muscle pain, or post-surgical pain. Doses are adjusted for weight and liver function. NSAIDs are used carefully if kidney or heart problems are present. Good pain control allows better sleep, mobility, and mood.
17. Antibiotics when infections occur
Antibiotics are not specific to mitochondrial disease, but early, appropriate antibiotics for bacterial infections are critical to prevent severe metabolic decompensation. Doctors also try to avoid drugs with known mitochondrial toxicity (for example, linezolid or certain antivirals) when safer options exist.
18. Anti-nausea medicines (such as ondansetron)
Vomiting and poor intake quickly worsen dehydration and acidosis. Safe anti-emetics like ondansetron can help children keep down fluids and medicines. They are usually given in short courses, with attention to heart rhythm (QT interval) in fragile patients.
19. Vitamin D and calcium supplementation
Low mobility and chronic illness increase the risk of weak bones. Vitamin D and calcium, given in doses adjusted to serum levels, help maintain bone health and reduce fracture risk. These are often included in long-term care plans for mitochondrial disease.
20. Multivitamin infusions in hospital
During severe illness requiring IV nutrition, multivitamin IV products (containing thiamine, riboflavin, niacin, vitamin C, etc.) are used to avoid deficiency and support mitochondrial enzymes. Dosing follows the product label, and care teams protect these solutions from light to preserve sensitive vitamins.
Dietary molecular supplements
These supplements are often used as part of a “mitochondrial cocktail.” Evidence varies, and most are not formally approved specifically for mitochondrial disease, but are widely used in practice under specialist guidance.
(Here I’ll keep each description shorter than 100 words to stay within your word limit, but still explain function and mechanism.)
-
Coenzyme Q10 – Lipid-soluble antioxidant in the mitochondrial respiratory chain, shuttling electrons between complexes I/II and III and helping ATP production; may reduce oxidative stress.
-
Riboflavin (B2) – Precursor of FMN and FAD, essential for many dehydrogenases; high doses support electron transfer in the respiratory chain; dose is individualized by weight.
-
Thiamine (B1) – Cofactor for pyruvate dehydrogenase and α-ketoglutarate dehydrogenase; may improve use of glucose and reduce lactic acid formation.
-
L-carnitine – Transports long-chain fatty acids into mitochondria and removes toxic acyl groups; supports energy production and reduces organic acyl build-up.
-
Alpha-lipoic acid – Antioxidant cofactor for mitochondrial enzyme complexes; may lower oxidative stress and support glucose metabolism.
-
Creatine – Energy buffer in muscle and brain; phosphocreatine stores can help regenerate ATP during high demand, possibly improving strength and endurance.
-
L-arginine or citrulline – Precursors for nitric oxide; may improve blood flow and have a role in some mitochondrial stroke-like episodes.
-
Omega-3 fatty acids – Anti-inflammatory lipids that may support cell membranes, including mitochondrial membranes, and cardiovascular health.
-
Vitamin D – Supports bone health, muscle function, and immune regulation; deficiency is common in chronically ill children and is corrected with tailored dosing.
-
Antioxidant vitamins C and E – Help neutralize reactive oxygen species and may reduce oxidative damage to mitochondrial proteins and membranes.
Always remember: dosing, combinations, and potential interactions must be checked by a metabolic specialist or clinical pharmacist.
Immunity-booster and regenerative / stem-cell-related approaches
At present, no regenerative drug or stem-cell therapy is approved specifically for VARS2-related combined oxidative phosphorylation deficiency. Research in mitochondrial medicine is ongoing, and any such treatment should only be given in controlled clinical trials.
-
Optimizing standard vaccines – Routine and sometimes extra vaccines (for example, influenza, pneumococcal) strengthen the immune system’s ability to prevent infections, indirectly protecting fragile mitochondria from stress.
-
Good nutritional and vitamin status – Adequate protein, calories, and key vitamins (A, C, D, E, B group) support immune cells and their mitochondrial function.
-
Experimental antioxidants and redox-active drugs (for example, EPI-743) – Investigational molecules targeting mitochondrial redox balance have been studied in some mitochondrial syndromes but are not routine care yet.
-
Mitochondria-targeted peptides (such as elamipretide in trials) – These experimental drugs try to stabilize mitochondrial membranes and improve function; they are still under study and not standard for COXPD20.
-
Gene and stem-cell-based research – Gene therapy and stem-cell approaches are being explored for some mitochondrial and metabolic diseases but remain experimental, with important risks and unanswered questions.
-
Immunoglobulin therapy in selected cases – In patients with proven immune deficiency and repeated infections, IV immunoglobulin may be offered, but this is decided case-by-case and is not specific to VARS2 disease.
Surgical options
Surgery in VARS2-related disease is always weighed very carefully because anesthesia and fasting increase metabolic risk. When surgery is necessary, it is done with mitochondrial-aware precautions.
-
Feeding tube (gastrostomy/PEG) – A tube placed directly into the stomach helps children who cannot safely swallow enough food. It allows reliable nutrition and medicines and reduces the risk of aspiration.
-
Cardiac pacemaker or implantable defibrillator – In some patients with dangerous arrhythmias or conduction problems, devices are implanted to keep heart rhythm safe and prevent sudden cardiac death.
-
Corrective heart surgery or transplantation – Rarely, severe cardiomyopathy may need advanced surgical interventions, including heart transplant, in highly selected cases.
-
Orthopedic surgery for contractures or scoliosis – Severe joint stiffness or spinal curvature may need surgery to improve positioning, comfort, and ease of care.
-
Tracheostomy and long-term ventilation – In advanced respiratory failure, a tracheostomy may allow more stable breathing support and easier airway care at home.
Prevention and risk-reduction
Completely preventing VARS2 mutations is not possible once a child is born, but many complications can be reduced with careful daily habits and genetic planning.
-
Genetic counseling for at-risk families before future pregnancies.
-
Early diagnosis in siblings with concerning symptoms.
-
Keeping vaccines up to date to reduce severe infections.
-
Avoiding prolonged fasting and dehydration, especially during illness.
-
Prompt treatment of fever, vomiting, or chest infections.
-
Regular heart and brain monitoring to catch problems early.
-
Avoiding drugs known to harm mitochondria when safer alternatives exist (for example, valproate if possible).
-
Planning surgeries carefully with mitochondrial-experienced anesthesiologists.
-
Maintaining balanced nutrition and avoiding extreme diets without specialist input.
-
Providing early developmental and educational support to reduce secondary complications.
What to eat and what to avoid
Diet plans must always be individualized, but general mitochondrial advice often includes:
-
Eat regular, frequent meals with enough carbohydrates to avoid low blood sugar.
-
Eat a balanced mix of complex carbs, proteins, and healthy fats (for example, olive oil, nuts, fish).
-
Eat plenty of fruits and vegetables rich in antioxidants and vitamins.
-
Eat adequate protein (unless restricted for another reason) to support muscle repair.
-
Drink enough fluids throughout the day and extra during illness or hot weather.
-
Avoid long periods without food or drink, especially overnight or when sick.
-
Avoid very high-sugar drinks and highly processed junk foods that give short energy “spikes” and crashes.
-
Avoid unsupervised extreme diets (very low-calorie, very low-carb, or fad diets) unless prescribed by metabolic specialists.
-
Avoid excessive caffeine or energy drinks, which may worsen palpitations or sleep.
-
Avoid alcohol and smoking in older patients, because they add extra oxidative and cardiovascular stress.
Some children with hard-to-control epilepsy may be put on a ketogenic diet by specialists, but this requires very close monitoring and is not safe to start alone.
When to see a doctor urgently
Families should contact doctors or emergency services immediately if they notice:
-
New or worsening seizures.
-
Fast breathing, trouble breathing, or bluish lips.
-
Sudden feeding refusal, frequent vomiting, or inability to drink.
-
Unusual sleepiness, confusion, or sudden loss of skills (for example, cannot sit or stand as before).
-
Chest pain, strong palpitations, or fainting.
-
High fever that does not respond to standard treatment.
Regular, non-emergency follow-up with a mitochondrial clinic is also important even when the child seems stable.
Frequently asked questions (FAQs)
1. Is combined oxidative phosphorylation deficiency due to VARS2 curable?
No. At present there is no cure. Treatment focuses on supporting each organ, reducing mitochondrial stress, and improving quality and length of life. Research into gene and mitochondrial-targeted therapies is ongoing.
2. How is this disease diagnosed?
Doctors combine clinical symptoms, brain and heart imaging, biochemical tests (such as lactate and respiratory chain enzymes), and genetic testing showing biallelic VARS2 variants. Muscle or skin biopsy may be used in some cases.
3. Is it always severe in infancy?
Many reported cases present in early infancy with serious heart and brain involvement, but severity can vary. Some children survive longer with intensive supportive care, and new variants continue to be described.
4. Can adults have VARS2-related disease?
Most published cases involve infants and children, but milder or later-onset forms may exist and could be under-recognized. Adults with unexplained cardiomyopathy or encephalopathy might be tested in specialized centers.
5. Are brothers and sisters at risk?
Yes. Because the condition is autosomal recessive, each pregnancy of carrier parents has a 25% chance of an affected child, 50% chance of a carrier, and 25% chance of an unaffected, non-carrier child.
6. Can this be prevented in future pregnancies?
Genetic counseling can discuss options such as carrier testing for relatives, prenatal diagnosis, or preimplantation genetic testing with IVF to select embryos without the disease-causing variants.
7. Why are so many vitamins and supplements used?
Many mitochondrial enzymes need vitamins and cofactors. Giving high doses attempts to “push” remaining enzyme function and reduce oxidative stress. The evidence is mixed but some patients report better energy or fewer crises.
8. Are there medicines that must be avoided?
Yes. Drugs with known mitochondrial toxicity (for example, valproate, some barbiturates, certain antibiotics or anesthetics) may worsen symptoms and are avoided when possible. Families often carry a list of “caution” drugs.
9. Can children with this disease go to school?
Many children do attend school with support. They may need shortened days, extra rest breaks, mobility aids, and learning support. Regular communication between school and medical team is important.
10. Will exercise make the disease worse?
Over-exertion can trigger fatigue, but carefully planned, low-intensity exercise programs can actually improve mitochondrial function and endurance. Exercise plans should be created by a physiotherapist who knows mitochondrial disease.
11. Is a special “mitochondrial diet” needed?
Most patients benefit from a well-balanced, frequent-meal diet, not from extreme or fad diets. Special diets, such as ketogenic diet for epilepsy, are only used when clearly indicated and under close medical control.
12. What is the long-term outlook?
Published cases often show serious disease with risk of early death, especially when severe cardiomyopathy and lactic acidosis are present. However, each child is unique, and supportive care has improved over time.
13. Are clinical trials available?
Some trials test antioxidants, mitochondrial-targeted peptides, or gene-based approaches for mitochondrial diseases in general. Families can ask their specialists or national mitochondrial foundations about ongoing studies.
14. How can families cope with the stress of this diagnosis?
Psychological counseling, support groups, respite care, and clear communication with the medical team can reduce fear and isolation. Shared decision-making helps families feel more in control.
15. What is the single most important message for caregivers?
Do not manage this condition alone. Partner closely with a mitochondrial or metabolic center, learn early warning signs, keep written emergency plans, and ask for emotional and practical support. Early action in illness and regular follow-up can make a real difference.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: February 19, 2025.